Magnetic resonance imaging signal changes at the intramuscular injection site in dogs: Comparison of medetomidine and saline

Intramuscular administration is a commonly used method for delivering sedatives and anesthetics in veterinary medicine. Previous studies have reported inflammation at the intramuscular injection site in laboratory animals and observed signal changes on MRI following intramuscular injections in humans. We hypothesized that following intramuscular injection, the site would exhibit T2 hyperintensity and contrast enhancement on MRI. To investigate this, this prospective study evaluated the pattern of signal changes and grade of T2 signal intensity and contrast enhancement over time after the intramuscular injection of medetomidine at a premedication dosage, comparing it to saline. MRI scans were performed immediately postinjection into the biceps femoris and quadriceps femoris muscles, as well as at 2, 8, 24, and 72 h, and 7 days postinjection. A semiquantitative scale was utilized to grade signal intensity and contrast enhancement. Both medetomidine and saline injections showed T2 hyperintensity immediately after injection and contrast enhancement from 2 h postinjection, manifesting as flame-shaped. These signal changes decreased up to 24 h postinjection (p < .05). The signal changes induced by medetomidine showed higher T2 hyperintense change and stronger contrast enhancement compared with saline at most time points, with the signal changes persisting for a longer duration (p < .05). These findings suggest that intramuscular administration of medetomidine induces a more severe tissue reaction compared with saline, and the results are expected to aid in the differentiation of various muscle diseases that present with similar MRI findings.